Clinical characteristics of Acinetobacter baumannii complex bacteremia in patients receiving total parenteral nutrition

Journal of the Chinese Medical Association

Volumn 75, Issue 3, 2012, Pages 102-108

  Yin, Ti ^a   Chiang, Mei Chun ^b   Liaw, Jen Jiuan ^c   Kuo, Shu Chen ^a,b   Chen, Te Li ^a,b   Katherine Wang, Kai Wei ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Acinetobacter baumannii; Bacteremia; Characteristics; Outcome; Total parenteral nutrition

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; CATHETER INFECTION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENOMICS; HUMAN; MALE; MORTALITY; NONHUMAN; RETROSPECTIVE STUDY; TOTAL PARENTERAL NUTRITION;

ACINETOBACTER BAUMANNII; ADULT; AGED; APACHE; BACTEREMIA; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PARENTERAL NUTRITION, TOTAL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84862796168     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2011.12.015     Document Type: Article

References (22)

1. Jeejeebhoy K.N. Total parenteral nutrition: potion or poison?. Am J Clin Nutr 2001, 74:160-163.
2. Chen H.S., Wang F.D., Lin M., Lin Y.C., Huang L.J., Liu C.Y. Risk factors for central venous catheter-related infections in general surgery. J Microbiol Immunol Infect 2006, 39:231-236.
3. Opilla M. Epidemiology of bloodstream infection associated with parenteral nutrition. Am J Infect Control 2008, 36:S173e5-S173e8.
4. Dijkshoorn L., Nemec A., Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007, 5:939-951.
5. Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008, 21:538-582.
6. Lee N.Y., Chang T.C., Wu C.J., Chang C.M., Lee H.C., Chen P.L., et al. Clinical manifestations, antimicrobial therapy, and prognostic factors of monomicrobial Acinetobacter baumannii complex bacteremia. J Infect 2010, 61:219-227.
7. Lee Y.T., Huang L.Y., Chiang D.H., Chen C.P., Chen T.L., Wang F.D., et al. Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan. Int J Antimicrob Agents 2009, 34:580-584.
8. Houang E.T., Chu Y.W., Chu K.Y., Ng K.C., Leung C.M., Cheng A.F. Significance of genomic DNA group delineation in comparative studies of antimicrobial susceptibility of Acinetobacter spp. Antimicrob Agents Chemother 2003, 47:1472-1475.
9. Lin Y.C., Sheng W.H., Chen Y.C., Chang S.C., Hsia K.C., Li S.Y. Differences in carbapenem resistance genes among Acinetobacterbaumannii, Acinetobacter genospecies 3 and Acinetobacter genospecies 13TU in Taiwan. Int J Antimicrob Agents 2010, 35:439-443.
10. Lim Y.M., Shin K.S., Kim J. Distinct antimicrobial resistance patterns and antimicrobial resistance-harboring genes according to genomic species of Acinetobacter isolates. J Clin Microbiol 2007, 45:902-905.
11. Chuang Y.C., Sheng W.H., Li S.Y., Lin Y.C., Wang J.T., Chen Y.C., et al. Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with Acinetobacter bacteremia. Clin Infect Dis 2011, 52:352-360.
12. Chen T.L., Siu L.K., Wu R.C., Shaio M.F., Huang L.Y., Fung C.P., et al. Comparison of one-tube multiplex PCR, automated ribotyping and intergenic spacer (ITS) sequencing for rapid identification of. Acinetobacter baumannii. Clin Microbiol Infect 2007, 13:801-806.
13. Chang H.C., Wei Y.F., Dijkshoorn L., Vaneechoutte M., Tang C.T., Chang T.C. Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J Clin Microbiol 2005, 43:1632-1639.
14. Huang L.Y., Chen T.L., Lu P.L., Tsai C.A., Cho W.L., Chang F.Y., et al. Dissemination of multidrug-resistant, class 1 integron-carrying Acinetobacter baumannii isolates in Taiwan. Clin Microbiol Infect 2008, 14:1010-1019.
15. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing: 20th informational supplement 2010, CLSI document M100-S20, Clinical and Laboratory Standards Institute, Wayne, PA.
16. Chen H.P., Chen T.L., Lai C.H., Fung C.P., Wong W.W., Yu K.W., et al. Predictors of mortality in Acinetobacter baumannii bacteremia. J Microbiol Immunol Infect 2005, 38:127-136.
17. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., Hughes J.M. CDC definitions for nosocomial infections. Am J Infect Control 1988, 16:128-140.
18. Paterson D.L. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis 2006, 43:S43-S48.
19. Kung S.P., Lui W.Y. Correlation between serum transferrin level and prognosis in patients receiving total parenteral nutrition. J Chin Med Assoc 2002, 65:392-397.
20. Lin L.Y., Lin H.C., Lee P.C., Ma W.Y., Lin H.D. Hyperglycemia correlates with outcomes in patients receiving total parenteral nutrition. Am J Med Sci 2007, 333:261-265.
21. Baran G., Erbay A., Bodur H., Onguru P., Akinci E., Balaban N., et al. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections. Int J Infect Dis 2008, 12:16-21.
22. Collins C.J., Fraher M.H., Bourke J., Phelan D., Lynch M. Epidemiology of catheter-related bloodstream infections in patients receiving total parenteral nutrition. Clin Infect Dis 2009, 49:1769-1770.